Current Affairs - Technology - Discussion

IICT, or the CSIR-Indian Institute of Chemical Technology, Hyderabad, signed a technology transfer agreement with Viridis Biopharma for an IND-ready phytopharmaceutical aimed at treating diabetic foot ulcers. The treatment was developed from Gymnema sylvestre and focuses on wound management. The project was developed by the Department of Applied Biology under the CSIR Phytopharmaceutical Mission Phase-III. It has completed pre-clinical development, botanical standardisation, and GLP-compliant safety studies and is now moving toward clinical trials and commercial development. Regulatory submissions are planned for India’s CDSCO and the US FDA.